Category Archives:

By Richard Cowan and Nolan D. McCaskill WASHINGTON, April 1 (Reuters) - Republican leaders in the U.S. Congress on Wednesday said they will take a two-pronged approach to ending the legislative deadlo...

April 1 (Reuters) - Shares of aerospace companies jumped on Wednesday as mounting anticipation of a blockbuster IPO from Elon Musk's SpaceX stirred hopes that the industry could see a renewed wave of ...

By Tom Polansek CHICAGO, March 31 (Reuters) - U.S. farmers plan to plant less corn and more soybeans in 2026 than last year, the U.S. Department of Agriculture said, as the Iran war drives up fertiliz...

By Jody Godoy April 1 (Reuters) - California and a group of states are seeking $10.3 million in fees and costs for helping block the Kroger-Albertsons merger, a bid that would refill the state's coffe...

By Echo Wang SAN FRANCISCO, April 1 (Reuters) - Rocket company SpaceX will host an analyst day on April 21, and will offer analysts a visit to its "Macrohard" xAI datacenter in Memphis, Tennessee two ...

By Suzanne McGee PROVIDENCE, Rhode Island, April 1 (Reuters) - Investment advisors say a buildup of problems is weighing on clients, who are entering the second quarter of the year struggling with try...

By Richa Naidu, Yadarisa Shabong and Alexander Marrow LONDON, April 1 (Reuters) - As a senior Unilever executive in Brazil some 15 years ago, Fernando Fernandez made a bold gamble on hair care and bea...

ROME, April 1 (Reuters) - Italian senators on Wednesday presented a draft law to tackle social media addiction that seeks to increase the responsibility of online platforms for the way content is dist...

By Nerijus Adomaitis OSLO, April 1 (Reuters) - An environmental activist vessel deliberately collided with a Norwegian krill harvesting vessel near Antarctica on Tuesday, damaging its hull, the vessel...

By Leah Douglas and Christy Santhosh April 1 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eli Lilly's weight-loss pill, making it the second to market after Novo Nordisk's o...